All GLP-1 medications from licensed 503A compounding pharmacies Browse Products

GLP-1 Dosage Guide: Complete Guide 2026

Complete GLP-1 dosage guide for 2026. Learn dosing schedules for semaglutide, tirzepatide, and liraglutide including escalation timelines and dose...

By Dr. James Walker, MD, MPH|Reviewed by Dr. David Kim, MD, FACE||

Medically Reviewed

Written by Dr. James Walker, MD, MPH · Reviewed by Dr. David Kim, MD, FACE

GLP-1 Dosage Guide: Complete Guide 2026 custom 2026 header image for GLP-1 Weight Loss
Custom header image for GLP-1 Dosage Guide: Complete Guide 2026, GLP-1 Weight Loss, and better treatment decision-making.
In This Article

This article is part of our GLP-1 Weight Loss collection. See also: Provider Comparisons | Peptide Guides

Search and AI answer brief

Practical answer: GLP-1 Dosage Guide: Complete Guide 2026

Complete GLP-1 dosage guide for 2026. Learn dosing schedules for semaglutide, tirzepatide, and liraglutide including escalation timelines and dose...

Short answer

Complete GLP-1 dosage guide for 2026. Learn dosing schedules for semaglutide, tirzepatide, and liraglutide including escalation timelines and dose...

Search intent

This page answers a specific GLP-1 Weight Loss question rather than a generic overview.

What to verify

semaglutide, tirzepatide, retatrutide, cash price and coverage terms

How to use it

Use this information to prepare sharper questions for a licensed provider.

Key Takeaway

Complete GLP-1 dosage guide for 2026. Learn dosing schedules for semaglutide, tirzepatide, and liraglutide including escalation timelines and dose adjustment strategies.

A GLP-1 dosage guide is important because every GLP-1 medication follows a specific dose escalation schedule designed to minimize side effects while building to therapeutic levels. Getting the dosing right is one of the most important factors in your treatment success. At FormBlends, our physicians carefully manage dose escalation for every patient, and this guide explains exactly how dosing works across all major GLP-1 medications.

Overview: Why Dose Escalation Matters

GLP-1 medications aren't started at their full therapeutic dose. Instead, treatment begins at a low dose and increases gradually over weeks or months. This approach serves two purposes:

  • Minimizes side effects: GI side effects like nausea are significantly reduced when the body has time to adjust to each dose level.
  • Finds the right dose for you: Not everyone needs the maximum dose. Some patients achieve excellent results at mid-range doses.

Tirzepatide (Mounjaro/Zepbound) Dosing Schedule

Weeks Dose Purpose Pen Color (Mounjaro)
1-4 2.5 mg weekly Initiation (not therapeutic) Yellow
5-8 5 mg weekly First therapeutic dose Red-brown
9-12 7.5 mg weekly Intermediate dose Green
13-16 10 mg weekly Higher therapeutic dose Teal
17-20 12.5 mg weekly Advanced dose Blue
21+ 15 mg weekly Maximum dose Purple

Semaglutide (Ozempic/Wegovy) Dosing Schedule

Wegovy (for weight management)

Weeks Dose Purpose
1-4 0.25 mg weekly Initiation
5-8 0.5 mg weekly Escalation
9-12 1.0 mg weekly Escalation
13-16 1.7 mg weekly Escalation
17+ 2.4 mg weekly Maintenance dose

Ozempic (for type 2 diabetes)

Weeks Dose Purpose
1-4 0.25 mg weekly Initiation
5-8 0.5 mg weekly First therapeutic dose
9+ 1.0 mg weekly Standard dose
If needed 2.0 mg weekly Maximum dose

Liraglutide (Saxenda/Victoza) Dosing Schedule

Week Daily Dose Purpose
1 0.6 mg Initiation
2 1.2 mg Escalation
3 1.8 mg Escalation
4 2.4 mg Escalation
5+ 3.0 mg Maintenance dose

Note that liraglutide is a daily injection, unlike the weekly schedules for tirzepatide and semaglutide.

Check your GLP-1 eligibility

Use our free BMI Calculator to see if you may qualify for provider-reviewed GLP-1 therapy.

Try the BMI Calculator →
GLP-1 Weight Loss Results by Medication Mean Body Weight Loss (%) 0 6 12 18 24 22 15 8 24 Tirzepatide Semaglutide Liraglutide Retatrutide Based on published STEP and SURMOUNT trial data
GLP-1 Weight Loss Results by Medication. Based on published STEP and SURMOUNT trial data.
View data table
Bar chart showing glp-1 weight loss results by medication: Tirzepatide (22), Semaglutide (15), Liraglutide (8), Retatrutide (24)
CategoryMean Body Weight Loss (%)Detail
Tirzepatide22~22% body weight at 72 wks
Semaglutide15~15% body weight at 68 wks
Liraglutide8~8% body weight at 56 wks
Retatrutide24~24% in Phase 2 trial
Illustration for GLP-1 Dosage Guide: Complete Guide 2026

Key Dosing Principles

1. Never Skip the Starting Dose

Even though the starting dose isn't therapeutic (meaning it won't produce significant weight loss), it serves a critical role in letting your body adjust. Jumping straight to a higher dose almost guarantees worse side effects.

2. Time Between Increases

The standard minimum is 4 weeks between dose increases. But your provider may recommend staying at a dose for 6-8 weeks if:

  • You're experiencing significant GI side effects
  • You're already seeing good weight loss at the current dose
  • You want to minimize side effect risk

3. You May Not Need the Maximum Dose

Clinical trials test the maximum dose to demonstrate the drug's full potential. In real-world practice, many patients achieve their goals at mid-range doses. Your provider should base dose decisions on your results and tolerance, not a one-size-fits-all protocol.

4. Dose Adjustments Go Both Ways

If a dose increase causes intolerable side effects, stepping back to the previous dose is perfectly acceptable. You can try increasing again later, or stay at the dose that works best for you.

Dosing Comparison Across GLP-1 Medications

Feature Tirzepatide Semaglutide Liraglutide
Frequency Once weekly Once weekly Once daily
Starting dose 2.5 mg 0.25 mg 0.6 mg
Maximum dose 15 mg 2.4 mg (Wegovy) 3.0 mg (Saxenda)
Escalation steps 6 levels 5 levels (Wegovy) 5 levels
Time to max dose ~20 weeks ~16 weeks ~5 weeks
Mechanism Dual GIP/GLP-1 GLP-1 only GLP-1 only

What Happens at Each Dose Level

Starting Dose (Week 1-4)

You may notice some appetite reduction and mild GI effects, but don't expect significant weight loss. This phase is about building tolerance. Some patients lose a few pounds simply from eating slightly less.

First Therapeutic Dose (Week 5-8)

This is where most patients begin to feel the real effects. Appetite suppression becomes more noticeable, and steady weight loss typically begins. Many patients report that "food noise" quiets down significantly at this stage.

Mid-Range Doses (Week 9-16)

Weight loss accelerates for most patients. Blood sugar improvements become measurable. This is where many patients find their sweet spot and may not need to go higher.

Higher Doses (Week 17+)

Maximum appetite suppression and metabolic effects. Patients who have plateaued at lower doses often see renewed progress. Not everyone reaches or needs these doses.

Factors That Influence Your Optimal Dose

  • Starting body weight: Higher body weight often requires higher doses for optimal results.
  • Side effect tolerance: Patients with sensitive GI systems may do better at moderate doses.
  • Weight loss goals: More aggressive goals may benefit from higher doses.
  • Blood sugar status: Diabetes patients may need higher doses for adequate glycemic control.
  • Concurrent medications: Some drug interactions may influence dosing decisions.
  • Rate of weight loss: If you're losing weight consistently at a current dose, there may be no reason to increase.

Cost Implications of Dosing

For brand-name medications, the cost per pen is typically the same regardless of dose. For compounded medications, higher doses often cost more because they require more active ingredient. This is another reason to find your minimum effective dose.

GLP-1 cost without insurance

Missed Doses

Tirzepatide or Semaglutide (Weekly)

  • If less than 4 days since the missed dose: take it as soon as you remember, then resume your regular schedule.
  • If more than 4 days: skip the missed dose and take the next one on your regular day.
  • Never take two doses at once or within a few days of each other.

Liraglutide (Daily)

  • If you miss a dose, take your regular dose the next day. Don't double up.
  • If you miss 3 or more days in a row, contact your provider about whether to restart at a lower dose.

Switching Between GLP-1 Medications

If you switch from one GLP-1 to another, your provider will determine the appropriate starting dose for the new medication. Common scenarios:

  • Semaglutide to tirzepatide: Typically start at 2.5 mg tirzepatide regardless of your semaglutide dose. Escalation may proceed faster since your body is already adjusted to a GLP-1.
  • Tirzepatide to semaglutide: Start at 0.25-0.5 mg depending on your provider's assessment.
  • Liraglutide to a weekly medication: Transition directly to the starting dose of the new weekly medication.

Getting Your Dosing Right at FormBlends

  1. Your physician evaluates your health profile and starts you at the appropriate dose.
  2. Regular check-ins during the escalation phase ensure you're tolerating each level.
  3. Dose increases are based on your individual response, not a rigid calendar.
  4. If side effects are an issue, your provider slows the timeline rather than pushing through.
  5. Your maintenance dose is determined by your results and comfort, not by defaulting to maximum.

GLP-1 online prescription

Frequently Asked Questions

What happens if I increase my dose too fast?

Increasing too quickly typically results in more severe nausea, vomiting, or diarrhea. If this happens, your provider can step you back to the previous dose and try the increase again later with a longer transition period.

Can I stay on a low dose permanently?

Yes. If a lower dose is providing adequate weight loss and you're tolerating it well, there's no requirement to increase. Your provider will discuss the trade-offs of staying at a lower dose versus escalating.

How do I know if my dose is too high?

Signs that a dose may be too high include persistent nausea (lasting more than 2-3 weeks), significant loss of appetite to the point of not eating enough, or severe GI symptoms. Talk to your provider about adjusting.

Does higher dose always mean more weight loss?

Generally, higher doses produce more weight loss in clinical trials. But the difference between mid-range and maximum doses may be modest for some patients. The best dose is the one that gives you meaningful results with manageable side effects.

What time of day should I take my GLP-1 dose?

For weekly injections (tirzepatide, semaglutide), choose any consistent day and time. Many patients prefer evenings so they sleep through initial GI effects. For daily liraglutide, any consistent time works.

Can I split my weekly dose into two smaller injections?

This isn't a standard practice and should only be done under physician guidance. Some providers use split dosing as a strategy for patients with severe nausea, but it isn't part of the standard protocol.

Get Personalized Dosing Support

Dosing isn't one-size-fits-all. The right dose for you depends on your body, your goals, and your tolerance. Our physician team at FormBlends personalizes every treatment plan and adjusts dosing based on your real-world experience. If you're ready to start GLP-1 therapy with expert guidance, we're here to help. get started with FormBlends

Research Snapshot

Provider comparison
Page type
Provider comparison
FormBlends review
Last reviewed
2026-04-01
FormBlends review
FormBlends official source
Official source
Mounjaro evidence source
Official source
Ozempic evidence source
Official source
Retatrutide evidence source
Official source
Saxenda evidence source
Official source
Semaglutide evidence source
Official source
Before you act
Check the current prescribing information, regulatory status, and trial source before treating an investigational or newly approved medication as interchangeable with an established therapy.
Check before ordering

Regulatory status, labels, trial records, and sponsor updates can change quickly for obesity-drug pipeline pages. This snapshot is designed to make verification easier, not to replace checking the official source before making a medical or purchase decision. Last page review: 2026-04-01.

Evidence standard

How this page was source-checked

Editorial policy

FormBlends does not claim an individual clinician byline unless a named reviewer is available. For this page, the editorial team checks medical and regulatory claims against primary sources, clinical trials, public datasets, and regulator guidance.

PubMed evidence trail

Research sources used to frame this page

For GLP-1 Dosage Guide: Complete Guide 2026, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.

Randomized trialSemaglutide evidence2021

Once-Weekly Semaglutide in Adults with Overweight or Obesity

Primary STEP 1 trial source for semaglutide weight-management efficacy and adverse-event context.

PubMed

Randomized trialSemaglutide evidence2021

Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance

Used for maintenance, discontinuation, and weight-regain discussions after semaglutide response.

PubMed

Randomized trialSemaglutide evidence2022

Effect of Weekly Subcutaneous Semaglutide vs Daily Liraglutide on Body Weight

Supports head-to-head context when pages compare older and newer GLP-1 options.

PubMed

Randomized trialTirzepatide evidence2022

Tirzepatide Once Weekly for the Treatment of Obesity

Primary SURMOUNT-1 trial source for tirzepatide weight-loss ranges and tolerability.

PubMed

Randomized trialTirzepatide evidence2024

Continued Treatment With Tirzepatide for Maintenance of Weight Reduction

Used for continuation, stopping, and maintenance questions after initial weight loss.

PubMed

Randomized trialTirzepatide evidence2025

Tirzepatide for Obesity Treatment and Diabetes Prevention

Supports newer discussion of obesity treatment and diabetes-prevention outcomes.

PubMed

Systematic reviewGLP-1 class evidence2025

Efficacy of GLP-1 Receptor Agonists on Weight Loss, BMI, and Waist Circumference

A broad meta-analysis anchor for GLP-1 weight-loss effect and class-level comparisons.

PubMed

Systematic reviewGLP-1 class evidence2025

Discontinuing glucagon-like peptide-1 receptor agonists and body habitus

Used for pages discussing stopping therapy, weight regain, and long-term planning.

PubMed

Systematic reviewGLP-1 class evidence2025

Effect of glucagon-like peptide-1 receptor agonists and co-agonists on body composition

Supports body-composition, lean-mass, and metabolic-risk context.

PubMed

GLP-1 decision path

Use this page to decide if a provider review is the right next step

Direct answer

GLP-1 Dosage Guide: Complete Guide 2026 research is most useful when it helps you compare eligibility, expected results, side effects, cost, and the supervision needed before treatment.

Evidence check

The strongest GLP-1 pages connect the practical answer to clinical trials, FDA labeling where applicable, and real access constraints.

Safety check

A licensed clinician still needs to review health history, contraindications, current medications, side effects, and dose escalation.

Next step

When the page matches your goal, continue into the FormBlends get-started flow so the intake can route you toward the right prescription review path.

FormBlends Editorial Context

Reviewed May 14, 2026

Complete GLP-1 dosage guide for 2026. Learn dosing schedules for semaglutide, tirzepatide, and liraglutide including escalation timelines and dose adjustment strategies. Before you use "GLP-1 Dosage Guide: Complete Guide 2026" to make a real decision, separate the headline answer from the details that could change it. The page connects dosing literacy and clinician follow-up with semaglutide, tirzepatide, dosing, inside a GLP-1 treatment guide where medication choice, dosing, side effects, monitoring, and insurance rules can change the decision. Because this article has 14 major sections, scan the headings first and then use the FAQ or summary sections to pressure-test the answer. Bring anything that changes dosing, pharmacy choice, cost, or safety to a licensed clinician.

  • Confirm whether the page is discussing an FDA-approved use, a compounded option, or research-only context.
  • Ask a licensed clinician how the evidence applies to your health history, medications, labs, and side-effect risk.
  • Check the latest label, trial update, pharmacy policy, or state rule when the article touches medication access.

Original tools and data

Use the FormBlends research stack

These assets are built to be useful beyond a single article: shareable data pages, calculators, provider comparisons, and safety checks that give Google and readers something original to crawl.

Editorial refresh

Practical 2026 note for GLP

This update makes GLP more specific by tying semaglutide, tirzepatide, retatrutide, cash-pay pricing, safety signals, glp to the page's original clinical, cost, access, or comparison angle.

The goal is to make the article more useful for people who already know the headline question and need page-level specifics, not another interchangeable glp-1 weight loss summary.

For 2026 review, the content emphasizes current verification, treatment fit, and patient-safety questions that can be discussed with a qualified provider.

GLP custom 2026 image for glp-1 weight loss on FormBlends

Custom 2026 image for GLP, glp-1 weight loss, and better treatment decision-making.

Image description: Unique image for this page covering GLP, glp-1 weight loss, safety, cost, provider selection, and patient decision-making.

Medical Disclaimer: This content is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider before starting, stopping, or changing any medication or treatment. FormBlends articles are source-checked against medical and regulatory references, but they are not a substitute for a personal medical consultation.

Written by Dr. James Walker, MD, MPH

Internal Medicine. This article was researched against primary regulatory, trial, prescribing, and manufacturer sources where available. Reviewed by Dr. David Kim, MD, FACE for medical accuracy, sourcing, and patient-safety framing.

Ready to get started?

Provider-reviewed GLP-1 and peptide therapy, delivered to your door.

Start Your Consultation

Ready to Start Your Weight Loss Journey?

Get a free medical consultation with a licensed provider. Compounded GLP-1 medications starting at $99/month with free shipping.

Next Best Reads

Free Tools

Provider-informed calculators to support your weight loss journey.